The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

103rd Annual Meeting of the American Urological Association

Managing Urinary Frequency and Urgency in Patients with LUTS and OAB

Orlando, Florida / May 17-22, 2008

Orlando - The standard of care for men with lower urinary tract symptoms (LUTS) remains alpha-blockers but symptoms often co-exist with those of an overactive bladder (OAB), i.e. frequency and urgency, and in some men, OAB is the primary...

XXIIIrd Congress of the European Association of Urology

The Patient Perspective on Overactive Bladder: A Matter of Urgency

Milan, Italy / March 26-29, 2008

Milan - The principal symptom of an overactive bladder (OAB) is “urgency”—an overwhelming desire to urinate. Although this leads to a marked deterioration in quality of life and increased depression and anxiety, the subject is often treated...

XXIIIrd Annual Congress of the European Association of Urology

CombAT and Prostate Health: Combination Strategies for Long-term Efficacy

Milan, Italy / March 26-29, 2008

Milan - The combination of an alpha blocker to relieve symptoms and improve flow plus a 5a-reductase inhibitor (5ARI) to reduce prostate volume is a rational strategy for men with lower urinary tract symptoms secondary to benign prostatic...

6th World Congress on the Aging Male

The Role of 5-Alpha Reductase Inhibition in Prostate Cancer and BPH: Lessons From Clinical Trials

Tampa, Florida / February 21-24, 2008

Tampa - In the 1990s, widespread acceptance of the prostate-specific antigen (PSA) assay led to a sharp increase in the detection and subsequent treatment of prostate cancer. The advent of PSA testing coincided with the introduction of the...

Based on the following published article: Clinical Interventions in Aging 2007;2(4):1-10.

Clinical Impact of Age-related Testosterone Depletion and Therapy

The march of time brings about many alterations to the endocrine system, including a reduction in hypothalamic-pituitary-testicular function and a variable decrease in testosterone. Both total and bioavailable testosterone levels are...

Overactive Bladder in Men: Appropriate Management Through Accurate Diagnosis

November 12, 2007

EDITORIAL OVERVIEW Sender Herschorn, MD, FRCSC, Professor and Chair, Department of Urology, University of Toronto, Toronto, Ontario PANEL Greg Bailly, MD, FRCSC, Department of Urology, Dalhousie University, Halifax, Nova Scotia Kevin V

29th Congress of the Société Internationale d’Urologie (SIU)

Benign Prostatic Hyperplasia: Emerging Findings on Combination Therapeutic Strategies

Paris, France / September 2-6, 2007

Paris - Benign prostatic hyperplasia (BPH) is the most common prostate disorder. Half of all males will have BPH by the time they are 50 years old and the incidence increases with age. Major concerns with this disease are related to surgery...

29th Congress of the Société Internationale d’Urologie

Improving Biopsy Detection and Reducing Prostate Volume

Paris, France / September 2-6, 2007

Paris - The majority of North American men have had a serum prostate-specific antigen test in their lifetime, with half being tested annually, yet more than 17% will be diagnosed with prostate cancer. Moreover, up to 30,000 men will die...

62nd Annual Meeting of the Canadian Urological Association

Optimizing Prostate Health: Implications of PCPT and MTOPS Trials

Quebec City, Quebec / June 24-27, 2007

Quebec City - In order to better manage patients with elevated prostate-specific antigen (PSA) levels, determine which patient with an elevated PSA to biopsy and decide when to prescribe a 5-alpha reductase inhibitor (5ARI) for men at high...

102nd Annual Meeting of the American Urological Association

Strategies to Optimize Prostate Health

Anaheim, California / May 19-24, 2007

Anaheim - Recent studies have provided valuable insight into the management of prostate disease, including benign prostatic hyperplasia (BPH) and the prevention of prostate cancer. BPH is commonly treated with alpha-adrenergic-receptor...

PAGE 5 OF 8   1 2 3 4 5 6 7 8